RecruitingNCT05559658

Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX

A Cross-sectional Descriptive Study Using Mixed Method (Qualitative and Quantitative) Data Collection


Sponsor

Institute of HIV Research and Innovation Foundation, Thailand

Enrollment

60 participants

Start Date

Feb 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The study is a two-phase observational study that assess multiple aspects of study and young men who have sex with men (YMSM). Phase I of the study will be a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) to acquire information necessary for developing a more extensive study on the same matter. Phase II of the study will be a prospective cohort study using a quantitative data collection. Findings from phase I will guide the development of phase II which consist of a larger number of YMSM, important baseline and follow-up questionnaires and comorbidities assessments, sexually transmitted infections testing, and integration to care. This protocol exclusively addresses the phase I of the study. Once the phase I findings are finalized, the principal investigator will submit the phase II to the IRB of the Faculty of Medicine, Chulalongkorn University.


Eligibility

Sex: MALEMin Age: 16 YearsMax Age: 35 Years

Inclusion Criteria12

  • Group 1A: Current chemsex users
  • Men who have sex with men
  • Aged 16-35 years
  • Able to communicate in Thai fluently
  • Current chemsex users
  • Provide informed consent
  • Group 1B: Former chemsex users (discontinued ≥90 days)
  • Men who have sex with men
  • Aged 16-35 years
  • Able to communicate in Thai fluently
  • Former chemsex users (discontinued ≥90 days)
  • Provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Institute of HIV Research and Innovation

Pathum Wan, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05559658


Related Trials